Paulo Luz

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Prognostic Factors

Metastatic Breast Cancer

Ejection Fraction

Top Venues

Postgraduate medical journal

Clinical drug investigation

European journal of breast health

This page only lists publications with an associated author ORCID identifier.

Publications

Inês Soares de Pinho, Paulo Luz, Lucy Alves, Raquel Lopes-Brás, Vanessa Patel, Miguel Esperança-Martins, Lisa Gonçalves, Ritas Freitas, Diana Simão, Maria Roldán Galnares, Isabel Fernandes, Silvia Artacho Criado, Salvador Gamez Casado, Jose Baena Cañada, Isabel M Saffie Vega, João G Costa, Ana S Fernandes, Rita Teixeira de Sousa, Luís Costa
Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence. Clinical drug investigation (2023)
Paulo Luz, Isabel Fernandes, Joana Magalhães, Rita Teixeira de Sousa, Pedro Faísca, João Guilherme Costa, Ana Fátima Carvalho Fernandes
Tumor-infiltrating lymphocytes in early breast cancer: an exploratory analysis focused on HER2+ subtype in Portuguese patients. Current medical research and opinion 38 (8) (2022)
Rita Gameiro-Santos, Isabel G Fernandes, Paulo Luz
Prognostication in Metastatic Solid Tumours: Medical Community General Knowledge. BMJ supportive & palliative care (2022)
Paulo Luz
Osler Centenary Papers: When the diagnosis is futile…. Postgraduate medical journal 95 (1130) (2020)
Paulo Luz
Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer? European journal of breast health 17 (1) (2020)
Paulo Luz, David Dias, Ana Fortuna, Luis Bretes, Beatriz Gosalbez
How shall we treat locally advanced triple negative breast cancer? F1000Research (2019)
Paulo Luz
Osler Centenary Papers: Reflection on the use of antibiotics to treat 'the old man's friend'. Postgraduate medical journal 95 (1130) (2019)
Paulo Luz, David Dias, Ana Fortuna, Luis Bretes, Beatriz Gosalbez
How shall we treat locally advanced triple negative breast cancer? F1000Research 8 (2019)